Acanthosis Nigricans project
Phase 3
- Conditions
- Acanthosis Nigricans.Acanthosis nigricans
- Registration Number
- IRCT20221129056666N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients with Acanthosis Nigricans lesions of axilla or neck.
Patients with the informed consent for participating in the study.
Exclusion Criteria
Pregnancy or Lactation
Patients with underlying malignancy.
Patients with contraindicatons for topical Tretinoin or Glycolic acid.
History of treatment of the lesions in the past month.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Degree of resolution of Acanthosis Nigricans lesions. Timepoint: 8 weeks after initiation of therapy and 4 treatment sessions. Method of measurement: Comparison with pre treatment photographs.
- Secondary Outcome Measures
Name Time Method